Article Information
History
- August 24, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jessica Gracias1,
- Funda Orhan1,
- Elin Hörbeck2,
- Jessica Holmén-Larsson2,
- Neda Khanlarkani1,
- Susmita Malwade1,
- Sravan K. Goparaju1,
- Lilly Schwieler1,
- Helena Fatourus-Bergman3,4,
- Aurimantas Pelanis5,
- Carleton P. Goold6,
- Anneli Goulding7,8,
- Kristina Annerbrink7,
- Anniella Isgren2,7,
- Timea Sparding2,
- Martin Schalling9,
- Viviana A. Carcamo Yañez10,
- Jens C. Göpfert10,
- Johanna Nilsson2,
- Ann Brinkmalm2,
- Kaj Blennow2,11,
- Henrik Zetterberg2,11,12,13,14,
- Göran Engberg1,
- Fredrik Piehl3,
- Steven D. Sheridan15,
- Roy H. Perlis15,
- Simon Cervenka3,16,
- Sophie Erhardt1,
- Mikael Landen2,17 and
- Carl M. Sellgren1,4,*
- 1Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
- 2The Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden
- 3Department of Clinical Neuroscience, Karolinska Institutet, Region Stockholm, Sweden
- 4Stockholm Health Care Services, Region Stockholm, Sweden
- 5Department of Anesthesiology, Sahlgrenska University Hospital, Gothenburg, Sweden
- 6Novartis Institutes of BioMedical Research, Cambridge, MA, USA
- 7Psychosis Clinic, Sahlgrenska University Hospital, Mölndal, Sweden
- 8Department of Psychology, University of Gothenburg, Gothenburg, Sweden
- 9Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
- 10NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany
- 11Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
- 12Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK
- 13UK Dementia Research Institute at UCL, London, UK
- 14Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China
- 15Center for Quantitative Health, Center for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA
- 16Department of Neuroscience, Uppsala University, Uppsala, Sweden
- 17Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
- ↵*Corresponding Author:
Carl M Sellgren, Dept. of Physiology and Pharmacology, Biomedicum C5, Tomtebodavägen 16, 171 65 Solna, Sweden. Phone: +46 (0) 70-212 72 87. Email: carl.sellgren{at}ki.se
Posted August 24, 2021.
Cerebrospinal fluid concentration of complement component 4A is increased in first-episode schizophrenia
